210 related articles for article (PubMed ID: 35125221)
1. A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Irving SA; Groom HC; Dandamudi P; Daley MF; Donahue JG; Gee J; Hechter R; Jackson LA; Klein NP; Liles E; Myers TR; Stokley S
Vaccine; 2022 Feb; 40(9):1246-1252. PubMed ID: 35125221
[TBL] [Abstract][Full Text] [Related]
2. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
[TBL] [Abstract][Full Text] [Related]
4. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
[TBL] [Abstract][Full Text] [Related]
5. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
[TBL] [Abstract][Full Text] [Related]
7. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496
[TBL] [Abstract][Full Text] [Related]
8. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
Walker TY; Elam-Evans LD; Singleton JA; Yankey D; Markowitz LE; Fredua B; Williams CL; Meyer SA; Stokley S
MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):874-882. PubMed ID: 28837546
[TBL] [Abstract][Full Text] [Related]
9. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M
Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243
[TBL] [Abstract][Full Text] [Related]
10. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.
Reagan-Steiner S; Yankey D; Jeyarajah J; Elam-Evans LD; Singleton JA; Curtis CR; MacNeil J; Markowitz LE; Stokley S
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(29):784-92. PubMed ID: 26225476
[TBL] [Abstract][Full Text] [Related]
11. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina.
Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS
Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834
[TBL] [Abstract][Full Text] [Related]
12. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.
Elam-Evans LD; Yankey D; Jeyarajah J; Singleton JA; Curtis RC; MacNeil J; Hariri S; ;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):625-33. PubMed ID: 25055186
[TBL] [Abstract][Full Text] [Related]
13. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
14. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
Arguedas A; Soley C; Loaiza C; Rincon G; Guevara S; Perez A; Porras W; Alvarado O; Aguilar L; Abdelnour A; Grunwald U; Bedell L; Anemona A; Dull PM
Vaccine; 2010 Apr; 28(18):3171-9. PubMed ID: 20189491
[TBL] [Abstract][Full Text] [Related]
16. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
17. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF
J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080
[TBL] [Abstract][Full Text] [Related]
18. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Fredua B; Singleton JA; Stokley S
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):718-723. PubMed ID: 31437143
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
Wheeler CM; Harvey BM; Pichichero ME; Simon MW; Combs SP; Blatter MM; Marshall GS; Catteau G; Dobbelaere K; Descamps D; Dubin G; Schuind A
Pediatr Infect Dis J; 2011 Dec; 30(12):e225-34. PubMed ID: 21817954
[TBL] [Abstract][Full Text] [Related]
20. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
